354 related articles for article (PubMed ID: 28546130)
1. A study of FoxA1 expression in thyroid tumors.
Nonaka D
Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
[TBL] [Abstract][Full Text] [Related]
2. Signification of forkhead box A1 (FOXA1) expression in thyroid cancers.
Missaoui N; Chouaibi S; Limam S; Mhamdi N; Zahmoul T; Hamchi H; Mokni M; Hmissa S
J Egypt Natl Canc Inst; 2019 Dec; 31(1):11. PubMed ID: 32372175
[TBL] [Abstract][Full Text] [Related]
3. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
Komminoth P; Roth J; Saremaslani P; Matias-Guiu X; Wolfe HJ; Heitz PU
Am J Surg Pathol; 1994 Apr; 18(4):399-411. PubMed ID: 8141431
[TBL] [Abstract][Full Text] [Related]
4. Epithelial markers in thyroid carcinoma: an immunoperoxidase study.
Wilson NW; Pambakian H; Richardson TC; Stokoe MR; Makin CA; Heyderman E
Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma.
Seok JY; Kang M; De Peralta-Venturina M; Fan X
Int J Surg Pathol; 2021 Sep; 29(6):615-626. PubMed ID: 33650906
[TBL] [Abstract][Full Text] [Related]
6. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
Simms A; Jacob RP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
[TBL] [Abstract][Full Text] [Related]
8. [Medullary thyroid carcinoma. Immunohistochemical markers in histopathology and research].
Schmid KW; Böcker W
Zentralbl Pathol; 1993 Jun; 139(2):115-29. PubMed ID: 8369268
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of galectin-3 in medullary thyroid carcinoma and C-cell hyperplasia.
Faggiano A; Talbot M; Lacroix L; Bidart JM; Baudin E; Schlumberger M; Caillou B
Clin Endocrinol (Oxf); 2002 Dec; 57(6):813-9. PubMed ID: 12460332
[TBL] [Abstract][Full Text] [Related]
10. Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19.
Deftos LJ; Woloszczuk W; Krisch I; Horvat G; Ulrich W; Neuhold N; Braun O; Reiner A; Srikanta S; Krisch K
Am J Med; 1988 Dec; 85(6):780-4. PubMed ID: 3195602
[TBL] [Abstract][Full Text] [Related]
11. GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas.
Davis DG; Siddiqui MT; Oprea-Ilies G; Stevens K; Osunkoya AO; Cohen C; Li XB
Hum Pathol; 2016 Jan; 47(1):26-31. PubMed ID: 26527523
[TBL] [Abstract][Full Text] [Related]
12. Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid.
Hirsch MS; Faquin WC; Krane JF
Mod Pathol; 2004 Jun; 17(6):631-6. PubMed ID: 15098009
[TBL] [Abstract][Full Text] [Related]
13. C-Cells and their Associated Lesions and Conditions: A Pathologists Perspective.
Baloch ZW; LiVolsi VA
Turk Patoloji Derg; 2015; 31 Suppl 1():60-79. PubMed ID: 26177318
[TBL] [Abstract][Full Text] [Related]
14. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
15. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases.
Matias-Guiu X; LaGuette J; Puras-Gil AM; Rosai J
Am J Surg Pathol; 1997 Jul; 21(7):754-62. PubMed ID: 9236831
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies.
Dasović-Knezević M; Børmer O; Holm R; Høie J; Sobrinho-Simões M; Nesland JM
Mod Pathol; 1989 Nov; 2(6):610-7. PubMed ID: 2587568
[TBL] [Abstract][Full Text] [Related]
17. Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ishizaki T
Mod Pathol; 1996 Jun; 9(6):631-5. PubMed ID: 8782199
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma.
González-Cámpora R; Galera-Ruiz D; Armas-Padrón JR; Otal-Salaverri C; Galera-Davidson H
Diagn Cytopathol; 1998 Jul; 19(1):4-8. PubMed ID: 9664176
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical analysis of malignant tumors of the thyroid gland using 6 relevant markers].
Brasanac D; Jancić-Zgurics M; Janković R; Tatić S
Srp Arh Celok Lek; 1993; 121(3-7):70-3. PubMed ID: 7716641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
